CAR-T cell therapy is rapidly expanding as a miraculous therapy for numerous malignancies. However, it also causes a variety of unique and severe side-effects, which frequently cause ICU admission. This chapter explores current approaches to complications including CRS (cytokine release syndrome), HLH (hemophagocytic lymphohistiocytosis), and ICANS (immune effector cell-associated neurotoxicity syndrome). Updates will be needed over time to keep this current – please don't hesitate to add additional information or alerts to fresh articles below.
-
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
- PulmCrit: ADAPT and SCREEN trials are full of sound and fury, signifying little - December 13, 2024
- PulmCrit: How to quickly create a useful professional account in BlueSky - November 28, 2024
- PulmCrit Wee: Why MedTwitter should move to Bluesky - November 15, 2024